{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:23:38Z","timestamp":1789500218566,"version":"build-2803163510"},"reference-count":75,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Glac Biotech Co., Ltd."}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>\n                    Metabolic-associated fatty liver disease (MAFLD) is predominantly associated with metabolic disturbances representing aberrant liver function and increased uric acid (UA) levels. Growing evidences have suggested a close relationship between metabolic disturbances and the gut microbiota. A placebo-controlled, double-blinded, randomized clinical trial was therefore conducted to explore the impacts of daily supplements with various combinations of the probiotics,\n                    <jats:italic>Lactobacillus fermentum<\/jats:italic>\n                    TSF331,\n                    <jats:italic>Lactobacillus reuteri<\/jats:italic>\n                    TSR332, and\n                    <jats:italic>Lactobacillus plantarum<\/jats:italic>\n                    TSP05 with a focus on liver function and serum UA levels. Test subjects with abnormal levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and UA were recruited and randomly allocated into six groups. Eighty-two participants successfully completed the 60-day intervention without any dropouts or occurrence of adverse events. The serum AST, ALT, and UA levels were significantly reduced in all treatment groups (\n                    <jats:italic>P<\/jats:italic>\n                    &lt; 0.05). The fecal microbiota analysis revealed the intervention led to an increase in the population of commensal bacteria and a decrease in pathobiont bacteria, especially\n                    <jats:italic>Bilophila wadsworthia<\/jats:italic>\n                    . The\n                    <jats:italic>in vitro<\/jats:italic>\n                    study indicated the probiotic treatments reduced lipid accumulation and inflammatory factor expressions in HepG2 cells, and also promoted UA excretion in Caco-2 cells. The supplementation of multi-strain probiotics (TSF331, TSR332, and TSP05) together can improve liver function and UA management and may have good potential in treating asymptomatic MAFLD.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Trial registration<\/jats:bold>\n                    . The trial was registered in the US Library of Medicine (clinicaltrials.gov) with the number NCT06183801 on December 28, 2023.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0307181","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T13:41:18Z","timestamp":1721828478000},"page":"e0307181","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Probiotic Lactobacillus fermentum TSF331, Lactobacillus reuteri TSR332, and Lactobacillus plantarum TSP05 improved liver function and uric acid management-A pilot study"],"prefix":"10.1371","volume":"19","author":[{"given":"Jia-Hung","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Huei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Wei","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2053-7214","authenticated-orcid":true,"given":"Chorng-An","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-Fen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-Yu","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chieh","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3661-1949","authenticated-orcid":true,"given":"Yen-Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko-Chiang","family":"Hsia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7780-7983","authenticated-orcid":true,"given":"Yao-Tsung","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3813-1914","authenticated-orcid":true,"given":"Hsieh-Hsun","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,7,24]]},"reference":[{"issue":"36","key":"pone.0307181.ref001","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.3748\/wjg.v23.i36.6549","article-title":"Treatment options for alcoholic and non-alcoholic fatty liver disease: A review","volume":"23","author":"S Singh","year":"2017","journal-title":"World J Gastroenterol"},{"key":"pone.0307181.ref002","unstructured":"Antunes C, Azadfard M, Hoilat GJ, Gupta M. Fatty Liver. StatPearls. Treasure Island (FL)2022."},{"issue":"26","key":"pone.0307181.ref003","doi-asserted-by":"crossref","first-page":"8393","DOI":"10.3748\/wjg.v20.i26.8393","article-title":"Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease","volume":"20","author":"N Toshikuni","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"1 Suppl","key":"pone.0307181.ref004","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"CD Byrne","year":"2015","journal-title":"J Hepatol"},{"key":"pone.0307181.ref005","doi-asserted-by":"crossref","first-page":"101238","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"J Heeren","year":"2021","journal-title":"Mol Metab"},{"key":"pone.0307181.ref006","doi-asserted-by":"crossref","first-page":"g4596","DOI":"10.1136\/bmj.g4596","article-title":"Non-alcoholic fatty liver disease","volume":"349","author":"N Sattar","year":"2014","journal-title":"BMJ"},{"key":"pone.0307181.ref007","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000484283","article-title":"Uric Acid as a Cause of the Metabolic Syndrome","volume":"192","author":"C King","year":"2018","journal-title":"Contrib Nephrol"},{"key":"pone.0307181.ref008","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biochi.2015.06.025","article-title":"Uric acid as a modulator of glucose and lipid metabolism","volume":"116","author":"WG Lima","year":"2015","journal-title":"Biochimie"},{"issue":"6","key":"pone.0307181.ref009","doi-asserted-by":"crossref","first-page":"E1032","DOI":"10.1152\/ajpendo.00518.2020","article-title":"High uric acid induces liver fat accumulation via ROS\/JNK\/AP-1 signaling","volume":"320","author":"D Xie","year":"2021","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"pone.0307181.ref010","doi-asserted-by":"crossref","first-page":"657856","DOI":"10.3389\/fendo.2021.657856","article-title":"Serum Uric Acid Is a Mediator of the Association Between Obesity and Incident Nonalcoholic Fatty Liver Disease: A Prospective Cohort Study","volume":"12","author":"Q Zhang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"pone.0307181.ref011","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s40618-019-01130-6","article-title":"High uric acid, reduced glomerular filtration rate and non-alcoholic fatty liver in young people with obesity","volume":"43","author":"P Di Bonito","year":"2020","journal-title":"J Endocrinol Invest"},{"issue":"9","key":"pone.0307181.ref012","article-title":"Relationship Between Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease in Non-Obese Patients","volume":"55","author":"A Oral","year":"2019","journal-title":"Medicina (Kaunas)"},{"issue":"17","key":"pone.0307181.ref013","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179221","article-title":"Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease","volume":"22","author":"H Yanai","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"43","key":"pone.0307181.ref014","doi-asserted-by":"crossref","first-page":"16079","DOI":"10.3748\/wjg.v20.i43.16079","article-title":"Gut microbiota and metabolic syndrome","volume":"20","author":"D Festi","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"10","key":"pone.0307181.ref015","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1172\/JCI129194","article-title":"The gut microbiome and metabolic syndrome","volume":"129","author":"K Dabke","year":"2019","journal-title":"J Clin Invest"},{"issue":"8","key":"pone.0307181.ref016","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00018-019-03011-w","article-title":"The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD)","volume":"76","author":"Z Safari","year":"2019","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"pone.0307181.ref017","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/CM9.0000000000000696","article-title":"Gut microbiota and metabolic syndrome","volume":"133","author":"PX Wang","year":"2020","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"pone.0307181.ref018","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12866-018-1197-5","article-title":"Disbiome database: linking the microbiome to disease","volume":"18","author":"Y Janssens","year":"2018","journal-title":"BMC Microbiol"},{"key":"pone.0307181.ref019","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/bs.pmbts.2020.04.006","article-title":"Diet, nutrients and the microbiome","volume":"171","author":"WJ Dahl","year":"2020","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"1","key":"pone.0307181.ref020","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1038\/s41467-018-05249-7","article-title":"Bilophila wadsworthia aggravates high fat diet induced metabolic dysfunctions in mice","volume":"9","author":"JM Natividad","year":"2018","journal-title":"Nat Commun"},{"issue":"8","key":"pone.0307181.ref021","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21082890","article-title":"Microbial Medicine: Prebiotic and Probiotic Functional Foods to Target Obesity and Metabolic Syndrome","volume":"21","author":"M Green","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"pone.0307181.ref022","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/14397595.2018.1442183","article-title":"Hypouricaemic effects of yoghurt containing Lactobacillus gasseri PA-3 in patients with hyperuricaemia and\/or gout: A randomised, double-blind, placebo-controlled study","volume":"29","author":"H Yamanaka","year":"2019","journal-title":"Mod Rheumatol"},{"issue":"1","key":"pone.0307181.ref023","doi-asserted-by":"crossref","first-page":"41","DOI":"10.15403\/jgld.2014.1121.271.kby","article-title":"A Multi-strain Probiotic Reduces the Fatty Liver Index, Cytokines and Aminotransferase levels in NAFLD Patients: Evidence from a Randomized Clinical Trial","volume":"27","author":"N Kobyliak","year":"2018","journal-title":"J Gastrointestin Liver Dis"},{"issue":"6","key":"pone.0307181.ref024","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.numecd.2018.03.001","article-title":"The effect of daily fortified yogurt consumption on weight loss in adults with metabolic syndrome: A 10-week randomized controlled trial","volume":"28","author":"M Mohammadi-Sartang","year":"2018","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"pone.0307181.ref025","doi-asserted-by":"crossref","first-page":"481651","DOI":"10.5402\/2013\/481651","article-title":"Health benefits of probiotics: a review","volume":"2013","author":"M Kechagia","year":"2013","journal-title":"ISRN Nutr"},{"issue":"6","key":"pone.0307181.ref026","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1053\/j.gastro.2020.01.031","article-title":"Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease","volume":"158","author":"E Scorletti","year":"2020","journal-title":"Gastroenterology"},{"issue":"8","key":"pone.0307181.ref027","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"C Hill","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"pone.0307181.ref028","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3892\/etm.2021.9619","article-title":"Lactobacillus spp. reduces ethanol-induced liver oxidative stress and inflammation in a mouse model of alcoholic steatohepatitis","volume":"21","author":"PS Hsieh","year":"2021","journal-title":"Exp Ther Med"},{"key":"pone.0307181.ref029","doi-asserted-by":"crossref","first-page":"e11209","DOI":"10.7717\/peerj.11209","article-title":"Lactobacillus reuteri TSR332 and Lactobacillus fermentum TSF331 stabilize serum uric acid levels and prevent hyperuricemia in rats","volume":"9","author":"YW Kuo","year":"2021","journal-title":"PeerJ"},{"issue":"9","key":"pone.0307181.ref030","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41575-021-00440-6","article-title":"The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics","volume":"18","author":"S Salminen","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"pone.0307181.ref031","doi-asserted-by":"crossref","DOI":"10.3390\/biom12111640","article-title":"Postbiotics and Their Health Modulatory Biomolecules","volume":"12","author":"E Scott","year":"2022","journal-title":"Biomolecules"},{"issue":"3","key":"pone.0307181.ref032","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.22207\/JPAM.16.3.19","article-title":"The Function of Mixed Postbiotic PE0401 in Improving Intestinal Health via Elevating Anti-inflammation, Anti-oxidation, Epithelial Tight Junction Gene Expression and Promoting Beneficial Bacteria Growth","volume":"16","author":"WY Lin","year":"2022","journal-title":"J Pure Appl Microbiol"},{"issue":"1","key":"pone.0307181.ref033","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/nar\/gks808","article-title":"Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies","volume":"41","author":"A Klindworth","year":"2013","journal-title":"Nucleic acids research"},{"key":"pone.0307181.ref034","volume-title":"16S Metagenomic sequencing library preparation","author":"P Amplicon","year":"2013"},{"issue":"W1","key":"pone.0307181.ref035","doi-asserted-by":"crossref","first-page":"W180","DOI":"10.1093\/nar\/gkx295","article-title":"MicrobiomeAnalyst: a web-based tool for comprehensive statistical, visual and meta-analysis of microbiome data","volume":"45","author":"A Dhariwal","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"pone.0307181.ref036","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3389\/fimmu.2018.01537","article-title":"Protective Effects of Lactic Acid Bacteria Against TLR4 Induced Inflammatory Response in Hepatoma HepG2 Cells Through Modulation of Toll-Like Receptor Negative Regulators of Mitogen-Activated Protein Kinase and NF-kappaB Signaling","volume":"9","author":"P Kanmani","year":"2018","journal-title":"Front Immunol"},{"issue":"9","key":"pone.0307181.ref037","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.jid.2019.12.036","article-title":"Threonine phosphorylation of I\u03baB\u03b6 mediates inhibition of selective proinflammatory target genes","volume":"140","author":"P Grondona","year":"2020","journal-title":"Journal of Investigative Dermatology"},{"key":"pone.0307181.ref038","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3389\/fcell.2020.00703","article-title":"Bergenin as a novel urate-lowering therapeutic strategy for hyperuricemia","volume":"8","author":"M Chen","year":"2020","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"pone.0307181.ref039","first-page":"1","article-title":"Claudin-1,-3 and-4 proteins and mRNA expression in benign and malignant breast lesions: a research study","volume":"7","author":"A-M T\u0151k\u00e9s","year":"2005","journal-title":"Breast Cancer Research"},{"issue":"9","key":"pone.0307181.ref040","article-title":"Probiotics in Irritable Bowel Syndrome: An Up-to-Date Systematic Review","volume":"11","author":"HF Dale","year":"2019","journal-title":"Nutrients"},{"key":"pone.0307181.ref041","doi-asserted-by":"crossref","first-page":"625913","DOI":"10.3389\/fcimb.2021.625913","article-title":"Role and Mechanism of Gut Microbiota in Human Disease","volume":"11","author":"Y Chen","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"pone.0307181.ref042","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41467-023-36079-x","article-title":"Microbially produced vitamin B12 contributes to the lipid-lowering effect of silymarin","volume":"14","author":"W-L Sun","year":"2023","journal-title":"Nature Communications"},{"key":"pone.0307181.ref043","article-title":"Bifidobacterium lactis Probio-M8 prevents nonalcoholic fatty liver disease in high-fat diet-fed rats: The potential role in modulating gut microbiota","author":"W Fan","year":"2024","journal-title":"Food Bioengineering"},{"issue":"2","key":"pone.0307181.ref044","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH","volume":"57","author":"L Zhu","year":"2013","journal-title":"Hepatology"},{"key":"pone.0307181.ref045","doi-asserted-by":"crossref","first-page":"934113","DOI":"10.3389\/fnut.2022.934113","article-title":"Gut microbiota\u2013mitochondrial inter-talk in non-alcoholic fatty liver disease","volume":"9","author":"Q Zhang","year":"2022","journal-title":"Frontiers in Nutrition"},{"issue":"1","key":"pone.0307181.ref046","doi-asserted-by":"crossref","first-page":"1851112","DOI":"10.1080\/20002297.2020.1851112","article-title":"Porphyromonas, Treponema, and Mogibacterium promote IL8\/IFNgamma\/TNFalpha-based pro-inflammation in patients with medication-related osteonecrosis of the jaw","volume":"13","author":"Q Li","year":"2020","journal-title":"J Oral Microbiol"},{"key":"pone.0307181.ref047","doi-asserted-by":"crossref","first-page":"814473","DOI":"10.3389\/fcimb.2022.814473","article-title":"From Mouth to Brain: Distinct Supragingival Plaque Microbiota Composition in Cerebral Palsy Children With Caries","volume":"12","author":"M Liu","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"pone.0307181.ref048","doi-asserted-by":"crossref","first-page":"11773","DOI":"10.1038\/s41598-017-11779-9","article-title":"Variations in oral microbiota associated with oral cancer","volume":"7","author":"H Zhao","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"pone.0307181.ref049","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.biologicals.2009.11.008","article-title":"Highlights of mycoplasma research\u2014an historical perspective","volume":"38","author":"S Razin","year":"2010","journal-title":"Biologicals"},{"issue":"1","key":"pone.0307181.ref050","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1631\/jzus.B0820256","article-title":"Mycoplasma lipoproteins and Toll-like receptors","volume":"10","author":"LL Zuo","year":"2009","journal-title":"J Zhejiang Univ Sci B"},{"issue":"18","key":"pone.0307181.ref051","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"DH Ipsen","year":"2018","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"pone.0307181.ref052","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","article-title":"Lipotoxicity and the gut-liver axis in NASH pathogenesis","volume":"68","author":"F Marra","year":"2018","journal-title":"J Hepatol"},{"key":"pone.0307181.ref053","doi-asserted-by":"crossref","first-page":"1024678","DOI":"10.3389\/fnut.2022.1024678","article-title":"The effects of supplementation of probiotics, prebiotics, or synbiotics on patients with non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials","volume":"9","author":"W Xing","year":"2022","journal-title":"Front Nutr"},{"key":"pone.0307181.ref054","doi-asserted-by":"crossref","first-page":"844242","DOI":"10.3389\/fnut.2022.844242","article-title":"Effect of probiotics on liver enzymes in patients with non-alcoholic fatty liver disease: an umbrella of systematic review and meta-analysis","volume":"9","author":"V Musazadeh","year":"2022","journal-title":"Frontiers in Nutrition"},{"issue":"21","key":"pone.0307181.ref055","doi-asserted-by":"crossref","first-page":"13522","DOI":"10.3390\/ijms232113522","article-title":"Postbiotics prepared using Lactobacillus paracasei CCFM1224 prevent nonalcoholic fatty liver disease by modulating the gut microbiota and liver metabolism","volume":"23","author":"Z Pan","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"9","key":"pone.0307181.ref056","article-title":"Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review","volume":"13","author":"HY Li","year":"2021","journal-title":"Nutrients"},{"issue":"11","key":"pone.0307181.ref057","doi-asserted-by":"crossref","first-page":"6249","DOI":"10.1111\/jocd.15228","article-title":"Novel application of a Co-Fermented postbiotics of TYCA06\/AP-32\/CP-9\/collagen in the improvement of acne vulgaris-A randomized clinical study of efficacy evaluation","volume":"21","author":"HH Ho","year":"2022","journal-title":"J Cosmet Dermatol"},{"issue":"4","key":"pone.0307181.ref058","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/14740338.2019.1594771","article-title":"Safety and tolerability of available urate-lowering drugs: a critical review","volume":"18","author":"L Strilchuk","year":"2019","journal-title":"Expert Opin Drug Saf"},{"key":"pone.0307181.ref059","doi-asserted-by":"crossref","first-page":"845684","DOI":"10.3389\/fimmu.2022.845684","article-title":"The Role of the Intestine in the Development of Hyperuricemia","volume":"13","author":"H Yin","year":"2022","journal-title":"Front Immunol"},{"key":"pone.0307181.ref060","doi-asserted-by":"crossref","first-page":"935723","DOI":"10.3389\/fcimb.2022.935723","article-title":"Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout","volume":"12","author":"Z Wang","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"pone.0307181.ref061","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3390\/microorganisms10050851","article-title":"Potential probiotic lacticaseibacillus paracasei MJM60396 prevents hyperuricemia in a multiple way by absorbing purine, suppressing xanthine oxidase and regulating urate excretion in mice","volume":"10","author":"Y Lee","year":"2022","journal-title":"Microorganisms"},{"key":"pone.0307181.ref062","first-page":"1","article-title":"The anti-hyperuricemic and gut microbiota regulatory effects of a novel purine assimilatory strain, Lactiplantibacillus plantarum X7022","author":"Y Zou","year":"2023","journal-title":"European Journal of Nutrition"},{"issue":"10","key":"pone.0307181.ref063","doi-asserted-by":"crossref","first-page":"105198","DOI":"10.1016\/j.isci.2022.105198","article-title":"Probiotic Limosilactobacillus fermentum GR-3 ameliorates human hyperuricemia via degrading and promoting excretion of uric acid","volume":"25","author":"S Zhao","year":"2022","journal-title":"iScience"},{"key":"pone.0307181.ref064","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.nut.2018.11.018","article-title":"Lactobacillus brevis DM9218 ameliorates fructose-induced hyperuricemia through inosine degradation and manipulation of intestinal dysbiosis","volume":"62","author":"H Wang","year":"2019","journal-title":"Nutrition"},{"issue":"1","key":"pone.0307181.ref065","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s40168-023-01605-y","article-title":"Lactiplantibacillus plantarum enables blood urate control in mice through degradation of nucleosides in gastrointestinal tract","volume":"11","author":"M Li","year":"2023","journal-title":"Microbiome"},{"key":"pone.0307181.ref066","doi-asserted-by":"crossref","first-page":"1111652","DOI":"10.3389\/fmicb.2023.1111652","article-title":"A randomized pilot trial assessing the reduction of gout episodes in hyperuricemic patients by oral administration of Ligilactobacillus salivarius CECT 30632, a strain with the ability to degrade purines","volume":"14","author":"JM Rodriguez","year":"2023","journal-title":"Front Microbiol"},{"issue":"4","key":"pone.0307181.ref067","doi-asserted-by":"crossref","DOI":"10.1093\/femsre\/fuad039","article-title":"Faecalibacterium: a bacterial genus with promising human health applications","volume":"47","author":"R Martin","year":"2023","journal-title":"FEMS Microbiol Rev"},{"issue":"3","key":"pone.0307181.ref068","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.mib.2013.06.003","article-title":"Faecalibacterium prausnitzii and human intestinal health","volume":"16","author":"S Miquel","year":"2013","journal-title":"Curr Opin Microbiol"},{"issue":"4","key":"pone.0307181.ref069","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/ismej.2016.176","article-title":"Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics","volume":"11","author":"M Lopez-Siles","year":"2017","journal-title":"ISME J"},{"issue":"12","key":"pone.0307181.ref070","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms10122382","article-title":"Akkermansia muciniphila and Faecalibacterium prausnitzii in Immune-Related Diseases","volume":"10","author":"R Effendi","year":"2022","journal-title":"Microorganisms"},{"issue":"8","key":"pone.0307181.ref071","doi-asserted-by":"crossref","first-page":"6855","DOI":"10.1039\/D0FO01009J","article-title":"Leuconostoc pseudomesenteroides improves microbiota dysbiosis and liver metabolism imbalance and ameliorates the correlation between dihydroceramide and strains of Firmicutes and Proteobacteria in high fat diet obese mice","volume":"11","author":"M Sun","year":"2020","journal-title":"Food Funct"},{"key":"pone.0307181.ref072","doi-asserted-by":"crossref","first-page":"1211831","DOI":"10.3389\/fmicb.2023.1211831","article-title":"Lactobacillus gasseri LG08 and Leuconostoc mesenteroides LM58 exert preventive effect on the development of hyperuricemia by repairing antioxidant system and intestinal flora balance","volume":"14","author":"L Liang","year":"2023","journal-title":"Front Microbiol"},{"issue":"1","key":"pone.0307181.ref073","first-page":"1","article-title":"Blautia-a new functional genus with potential probiotic properties?","volume":"13","author":"X Liu","year":"2021","journal-title":"Gut Microbes"},{"issue":"1","key":"pone.0307181.ref074","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1038\/s41467-022-32015-7","article-title":"Oral administration of Blautia wexlerae ameliorates obesity and type 2 diabetes via metabolic remodeling of the gut microbiota","volume":"13","author":"K Hosomi","year":"2022","journal-title":"Nat Commun"},{"issue":"3","key":"pone.0307181.ref075","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s12602-023-10044-y","article-title":"Potential Probiotic Properties of Blautia producta Against Lipopolysaccharide-Induced Acute Liver Injury","volume":"15","author":"B Mao","year":"2023","journal-title":"Probiotics Antimicrob Proteins"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0307181","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T13:42:41Z","timestamp":1721828561000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0307181"}},"subtitle":[],"editor":[{"given":"Imad","family":"Al Kassaa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,7,24]]},"references-count":75,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0307181","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,24]]}}}